The function of leptin in nutrition, weight, and physiology

Nutrition Reviews

Volumn 60, Issue 10 I, 2002, Pages

  Friedman, Jeffrey M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Adipocyte hormone; Energy balance; Leptin; Obesity; Regulating body weight

Indexed keywords

LEPTIN; LEPTIN RECEPTOR;

ADIPOCYTE; BODY WEIGHT; CONFERENCE PAPER; ENERGY BALANCE; GENE MUTATION; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; MAMMAL; METABOLISM; NEGATIVE FEEDBACK; NEUROENDOCRINE SYSTEM; NONHUMAN; NUTRITION; OBESITY; REGULATORY MECHANISM; WEIGHT GAIN; WEIGHT REDUCTION;

MAMMALIA;

EID: 0036790520     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/002966402320634878     Document Type: Conference Paper

References (111)

1. Wadden TA. Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials. Ann Intern Med 1993;119:688-693
2. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770
3. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc (Lond) (B) 1953;140:578-592
4. Calle E, Thun M, Petrelli J, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-1105
5. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med 1990;322:1483-1487
6. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546
7. Zhang Y, Proenca P, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432
8. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978;14:141-148
9. Cohen SL, Halaas JL, Friedman JM, et al. Characterization of endogenous human leptin. Nature 1996;382:589
10. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1(11):1155-1161
11. Halaas JL, Boozer C, Blair-West J, et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A 1997;94:8878-8883
12. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996;87: 377-389
13. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252
14. Lord G. Leptin modulates the T-cell immune response and reverses starvation induced immunosuppression. Nature 1998;394:897-901
15. Frisch RE, McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974;185:949-951
16. Chehab FF, Mounzih K, Lu R, Lim ME. Early onset of reproductive function in normal female mice treated with leptin. Science 1997;275(5296):88-90
17. Mantzoros CS, Flier JS, Rogol AD. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997;82(4):1066-1070
18. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-1271
19. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632-635
20. Pas and other db/db mice. J Biol Chem 1998;273: 10078-10082
21. Glaum SR, Hara M, Bindokas VT, et al. Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol Pharmacol 1996;50:230-235
22. Heisler LK, Cowley MA, Tecott LH, et al. Activation of central melanocortin pathways by fenfluramine. Science 2002;297:609-611
23. Sierra-Honigmann M, Nath A, Murakami C, et al. Biologic action of leptin as an angiogenic factor. Science 1998;281:1683-1686
24. Wang MY, Koyama K, Shimabukuro M, et al. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc Natl Acad Sci U S A 1998;95(2):714-718
25. Ghilardi N, Ziegler S, Wiestner A, et al. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A 1996;93:6231-6235
26. Fei H, Okano HJ, Li C, et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A 1997;94:7001-7005
27. Ioffe E, Moon B, Connolly E, Friedman JM. Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc Natl Acad Sci U S A 1998;95: 11852-11857
28. Choi SJ, Sparks R, Clay M, Dallman M. Rats with hypothalamic obesity are insensitive to central leptin injections. Endocrinology 1999;140:4426-4433
29. Hoggard N, Mercer JG, Rayner DV, et al. Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochem Biophys Res Commun 1997;232(2):383-387
30. Luiten PGM, Horst GJ, Steffens AB. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog Neurobiol 1987;28: 1-54
31. Friedman JM. The alphabet of weight control. Nature 1997;385:119-120
32. Stephens TW, Bashinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-534
33. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996;274(5293): 1704-1707
34. Pedrazzini T, Seydoux J, Kustner P, et al. Cardiovascular response, feeding behavior, and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 1998;4:722-726
35. Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD. Role of the Y5 neuropeptide Y receptor in feeding and seizures. Proc Natl Acad Sci U S A. In press
36. Naveilhan P, Hassani H, Canals J, et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat Med 1999;5:1188-1193
37. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141
38. Fan W, Boston BA, Kesterson RA, et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997;385:165-168
39. Hakansson M-L, Brown H, Ghilardi N, et al. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998;18:559-572
40. Cowley M, Smart J, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001;411:480-484
41. Ollmann MM, Wilson BD, Yang Y, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278:135-138
42. Shutter JR, Graham M, Kinsey AC, et al. Hypothalmic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 1997;11:593-602
43. Qu D, Ludwig DC, Gammeltoft S, et al. A role for melanin-concentrating hormone in the central regulation of feeding behavior. Nature 1996;380:243-247
44. Shimada M, Tritos N, Lowell B, et al. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998;396:670-674
45. Gibbs J, Young RC, Smith GP. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 1973;245:323-325
46. Smith GP, Jerome C, Cushin BJ, et al. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981;213:1036-1037
47. Matson CA, Wiater MF, Kuijper JL, Weigie DS. Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake. Peptides 1997;18: 1275-1278
48. Kristensen P, Judge ME, Thim L, et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998;393:72-76
49. Ohi-Hamazaki H, Watase K, Yamamoto K, et al. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 1997; 390:165-169
50. Woods AJ, Stock MJ. Leptin activation in hypothalamus. Nature 1996;381:745
51. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-585
52. Siegel J. Narcolepsy: a key role for hypocretins (orexins). Cell 1999;98:409-412
53. Gray TS, Carney ME, Magnuson DJ. Direct projects from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 1989;50:433-446
54. Cummings S, Elde R, Ells J, Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 1983;3:1355-1368
55. Merchenthaler I, Hynes M, Vigh S, et al. Corticotropin releasing factor (CRF): origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus. Neuroendocrinology 1984; 39:296-306
56. Arase K, York D, Shimizu H, et al. Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am J Physiol 1988;255:E255-E259
57. Rohner-Jeanrenaud F, Walker C-L, Greco-Perotto R, Jeanrenaud B. Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 1989;124:733-739
58. Schwartz MW, Baskin DG, Bukowski TR, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45(4):531-535
59. Elmquist JK, Ahima RS, Maratos-Flier E, et al. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 1997;138(2): 839-842
60. Heiman ML, Ahima RS, Craft LS, et al. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997; 138:3859-3863
61. Pepin MC, Pothier F, Barden N. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 1992;355:725-728
62. Langley SC, York DA. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucher rats. Am J Physiol 1990;259:R539-R544
63. Freedman MR, Horwitz BA, Stern JS. Effect of adrenalectomy and glucocorticoid replacement on development of obesity. Am J Physiol 1986;250: R595-R607
64. Di Marzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001;410:822-825
65. Yamada M, Miyakawa T, Duttaroy A, et al. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 2001;410: 207-212
66. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-198
67. DeFalco J, Tomishima M, Liu H, et al. Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science 2001;291:2608-2613
68. Verploegen S, Plaetinck G, Devos R, et al. A human leptin mutant induces weight gain in normal mice. FEBS Lett 1997;405(2):237-240
69. Loten EG, Rabinovitch A, Jeanrenaud B. In vivo studies in obese hyperglycaemic (ob/ob) mice: possible role of hyperinsulinaemia. Diabetologia 1974;10:45-52
70. Chen G, Koyama K, Yuan X, et al. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci U S A 1996;93(25):14795-14799
71. Levin N, Nelson C, Gurney A, et al. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci U S A 1996;93:1726-1730
72. Soukas A, Cohen P, Socci ND, Friedman JM. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 2000;14(8):963-980
73. Pelleymounter MA, Cullen MJ, Baker MD, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-543
74. Chinookoswong N, Wang J, Shi Z. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 1999; 48:1487-1492
75. Shimomura I, Hammer R, Ikemoto S, et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401:73-76
76. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 1992; 258:766-770
77. Randle PJ, Garland PB, Newsholmer EA, Hales CN. The glucose fatty-acid cycle in obesity and maturity onset diabetes mellitus. Ann N Y Acad Sci 1965;131:324-333
78. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171-176
79. Kim J, Fillmore J, Chen Y, et al. Tissue specific overexpression of lipoprotein lipase causes tissue specific insulin resistance. Proc Natl Acad Sci U S A 2001;98:7522-7527
80. Considine RV, Considine EL, Williams CJ, et al. The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996;45(7):992-994
81. Frederich RC, Hamn A, Anderson S, et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995;1:1311-1314
82. Zimmet P, Arblaster M, Thoma K. The effect of westernization on native populations. Studies on a Micronesian community with a high diabetes prevalence. Aust N Z J Med 1978;8(2):141-146
83. York B, Lei K, West DB. Inherited non-autosomal effects on body fat in F2 mice derived from an AKR/J x SWR/J cross. Mann. Genome 1997;8:726-30
84. West DB, Boozer CN, Moody DL, Atkinson RL. Obesity induced by a high fat diet in nine strains of inbred mice. Am J Physiol 1992;262:R1025-R1032
85. Ravussin E, Pratley RE, Maffei M, et al. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med 1997;3:238-240
86. Schwartz MW, Peskind E, Raskind M, et al. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996; 2:589-593
87. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996;348(9021):159-161
88. Fujioka K, Patane J, Lubina J, Lau D. CSF leptin levels after exogenous administration of recombinant methionyl human leptin. JAMA 1999;282: 1517-1518
89. Golden PL, Maccagnan TJ, Pardridge WM. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest 1997;99:14-18
90. Banks WA, Kastin AJ, Huang W, et al. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305-311
91. Banks W, DiPalma C, Farrell C. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999;20:1341-1345
92. Tartaglia LA. The leptin receptor. J Biol Chem 1997;272(10):6093-6096
93. White DW, Kuropatwinski KK, Devos R, et al. Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J Biol Chem 1997;272: 4065-4071
94. Bjorbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997; 272(51):32686-32695
95. Vaisse C, Halaas JL, Horvath CM, et al. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996;14:95-97.
96. Carpenter LR, Farruggella TJ, Symes A, et la. Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with ob receptor. Proc Natl Acad Sci U S A 1998;95:6061-6066
97. Li C, Friedman J. Leptin receptor activation of SH2 domain protein tyrosone phosphatase 2 modulates ob receptor signal transduction. Proc Natl Acad Sci U S A 1999;96:9677-9682
98. Bjorbaek C, Elmquist JK, Frantz JD, et al. Identification of SOC-3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619-625
99. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387:903-908
100. Strobel A, Camoin TIL, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18: 213-215
101. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401
102. Yeo G, Farooqi I, Aminian S, et al. A frameshift mutation in MC4R associated with dominatly inherited human obesity. Nat Genet 1998;20:111-112
103. Comuzzie AG, Hixson JE, Almasy L, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997;15:273-276
104. Krude H, Biebermann H, Luck W, et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998;19:155-157
105. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997;16:303-306
106. Blackburn G. Effect of degree of weight loss on health benefits. Obes Res 1995;3:211s-216s
107. Sjostrom CD, Lissner L, Sjostrom L. Relationships between changes in body compostition and changes in cardiovascular risk factors: the SOS Intervention Study. Obes Res 1997;5:519-530
108. Farooqi I, Jebb S, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879-884
109. Heymsfield S, Greenberg A, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults. JAMA 1999;282:1568-1575
110. Kamohara S, Burcelin R, Halaas JL, et al. Acute intravenous and intracerebroventricular leptin infusion increases glucose uptake and glucose turnover by an insulin independent mechanism. Nature 1997;389:374-377
111. Sivitz WI, Walsh SA, Morgan DA, et al. Effects of leptin on insulin sensitivity in normal rats. Endocrinology 1997;138:3395-3401